CSIMarket
 
Harpoon Therapeutics Inc   (NASDAQ: HARP)
 

Harpoon Therapeutics Inc's Customers Performance

HARP



 
HARP's Source of Revenues During the corresponding time, Harpoon Therapeutics Inc saw a revenue deteriorated by -67.33 % year on year, sequentially revenue fell by -78 %. While revenue at the Harpoon Therapeutics Inc 's corporate clients

List of HARP Customers




for the same period Harpoon Therapeutics Inc revnue deteriorated by -67.33 % year on year, sequentially revenue fell by -78 %.

List of HARP Customers

Harpoon Therapeutics Inc's Business Units






Harpoon Therapeutics Inc's Comment on Sales, Marketing and Customers
















HARP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Harpoon Therapeutics Inc 90.84 8.79 30.64 30
SUBTOTAL 0.00 0.00 0.00 -

Sources: Harpoon Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Harpoon Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Harpoon Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.